Key Insights

Highlights

Success Rate

68% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

18.2%

6 terminated out of 33 trials

Success Rate

68.4%

-18.1% vs benchmark

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

31%

4 of 13 completed with results

Key Signals

4 with results68% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (9)
P 1 (10)
P 2 (3)
P 4 (2)

Trial Status

Completed13
Recruiting6
Terminated6
Not Yet Recruiting3
Active Not Recruiting2
Unknown2

Trial Success Rate

68.4%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (33)

Showing 20 of 20 trials
NCT07517198Phase 1Recruiting

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

NCT03623464Not ApplicableActive Not Recruiting

RCT of Mobile Apps & FitBit v. Usual Care

NCT06637943Not Yet Recruiting

Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy

NCT06731998Not ApplicableRecruiting

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

NCT07034950Phase 1Active Not Recruiting

Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation

NCT04609410Not ApplicableTerminated

Bleeding in Laparoscopic Liver Surgery

NCT05788484Phase 1Completed

A Study of CDX-585 in Patients With Advanced Malignancies

NCT06994130Not Yet RecruitingPrimary

Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis

NCT06342414Recruiting

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

NCT04028479Completed

The Registry of Oncology Outcomes Associated with Testing and Treatment

NCT06718153Not ApplicableRecruitingPrimary

Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation

NCT04517448Terminated

Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy

NCT02649868Not ApplicableTerminatedPrimary

LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors

NCT06492408Phase 2RecruitingPrimary

Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.

NCT05957822Phase 4Recruiting

Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery

NCT03329950Phase 1Completed

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

NCT06245785CompletedPrimary

Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function

NCT02834780Phase 1Completed

Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma

NCT05750329Not ApplicableNot Yet Recruiting

Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC)

NCT04440943Phase 1Completed

A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

Scroll to load more

Research Network

Activity Timeline